CIK 0001787740 · <br>Emerging growth company
Valion Bio, Inc.
Sign in to watch- Ticker
- VBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814016391
- Phone
- (888)276-6888
- Business address
- 1305 E. HOUSTON STREET, BUILDING 1, SUITE 311, SAN ANTONIO, TX, 78205
- Former names
- Tivic Health Systems, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-18 | Ernst Jennifer Chief Executive Officer | Option exercise · Restricted Stock Units | −14,706 | 14,706 | ||
| 2025-09-22 | Ernst Jennifer Chief Executive Officer | Grant or award | +22,541 | 23,247 | ||
| 2025-08-06 | Wolf Lisa G Chief Financial Officer | Grant or award · Employee Stock Option (Right to Purchase) | +80,000 | 80,000 | ||
| 2025-08-06 | Handley Michael K Chief Operating Officer | Grant or award · Employee Stock Option (Right to Purchase) | +45,000 | 45,000 | ||
| 2025-08-06 | Ernst Jennifer Chief Executive Officer | Grant or award · Employee Stock Option (Right to Purchase) | +85,000 | 85,000 | ||
| 2025-08-06 | Zikria Dean Director | Grant or award · Stock Option (Right to Purchase) | +7,500 | 7,500 | ||
| 2025-08-06 | Wolf Lisa G Chief Financial Officer | Grant or award · Employee Stock Option (Right to Purchase) | +80,000 | 80,000 | ||
| 2025-08-06 | Valauri Christina Rizopoulos Director | Grant or award · Stock Option (Right to Purchase) | +7,500 | 7,500 | ||
| 2025-08-06 | Handley Michael K Chief Operating Officer | Grant or award · Employee Stock Option (Right to Purchase) | +45,000 | 45,000 | ||
| 2025-08-06 | Ernst Jennifer Chief Executive Officer | Grant or award · Employee Stock Option (Right to Purchase) | +85,000 | 85,000 | ||
| 2025-08-06 | Bolton Sheryle Director | Grant or award · Stock Option (Right to Purchase) | +12,500 | 12,500 | ||
| 2025-02-21 | Handley Michael K Chief Operating Officer | Grant or award · Restricted Stock Units | +600,000 | 600,000 | ||
| 2024-12-18 | Zikria Dean Director | Grant or award · Stock Option (Right to Purchase) | +12,000 | 12,000 | ||
| 2024-12-18 | Gurfein Blake Chief Scientific Officer | Grant or award · Restricted Stock Units | +225,000 | 225,000 | ||
| 2024-12-18 | Ernst Jennifer Chief Executive Officer | Grant or award · Restricted Stock Units | +500,000 | 500,000 | ||
| 2024-12-18 | Wolf Lisa G Interim CFO | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2024-12-18 | Bolton Sheryle Director | Grant or award · Stock Option (Right to Purchase) | +15,000 | 15,000 | ||
| 2024-12-18 | Valauri Christina Rizopoulos Director | Grant or award · Stock Option (Right to Purchase) | +12,000 | 12,000 | ||
| 2024-08-09 | Valauri Christina Rizopoulos Director | Grant or award · Employee Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2024-08-09 | Bolton Sheryle Director | Grant or award · Employee Stock Option (Right to Buy) | +3,000 | 3,000 |
Page 2 of 4 · 70 trades